Cocrystal Pharma Inc. (COCP)
NASDAQ · Healthcare
Cocrystal Pharma Inc. Shareholder Equity 2011–2020
Cocrystal Pharma Inc. annual/quarterly shareholder equity history from 2011 to 2020. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Cocrystal Pharma Inc. shareholder equity for the quarter ending December 31, 2020 were 52.5M, a 104.24% increase year-over-year.
- Cocrystal Pharma Inc. shareholder equity for 2020 were 52.5M, a 104.24% increase from 2019.
- Cocrystal Pharma Inc. shareholder equity for 2019 were 25.7M, a 1028.38% decrease from 2011.
- Cocrystal Pharma Inc. shareholder equity for 2011 were -2.8M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Cocrystal Pharma Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2020 | $53 |
| 2019 | $26 |
| 2011 | $-3 |
| Cocrystal Pharma Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2020-12-31 | $53 |
| 2019-12-31 | $26 |
| 2011-12-31 | $-3 |
Cocrystal Pharma Inc. Shareholder Equity — FAQ
Cocrystal Pharma Inc. (COCP) shareholder equity over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see COCP's shareholder equity history?
The chart and table above show Cocrystal Pharma Inc.'s shareholder equity by year and by quarter, including the growth rate.